MedPath

Effect of Hyaluronic Acid on the Therapy of Alveolar Osteitis

Not Applicable
Conditions
Alveolar Osteitis
Interventions
Device: Hyaluronic acid gel
Device: Hyaluronic acid gel + carrier
Registration Number
NCT04853589
Lead Sponsor
Medical University of Vienna
Brief Summary

Alveolar osteitis (AO; syn. dry socket) is one of the most frequent complications following tooth removal and it is defined as presence of severe postoperative pain in and around the extraction site, which increases in severity at any time between one and three days after extraction, accompanied by a partially or completely disintegrated blood cloth within the alveolar socket, with or without halitosis, and at the same time excluding any other cause for the pain (Blum 2002). To enhance standard treatment of AO, which consists of curettage of the dry socket, rinsing with saline solution, and inducing bleeding from the exposed alveolar bone walls, numerous products have been tested. One of them is hyaluronic acid (HY). The aim of the present study is to investigate the potential effect of HY gel application in the treatment of AO. Specifically, the application of HY only (HY test group; n = 20) or the combination of HY and an absorbable collagen sponge (HY+C test group; n = 20) will be compared to standard treatment (blood clot; control group, n=20). Clinical and patient related outcome parameters will be recorded for up to 14 days after treatment. A more stable blood clot and thus improved wound healing with faster pain reduction is expected through the use of HY.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria
  1. > 18 years;
  2. Untreated AO after extraction of a permanent tooth (excluding wisdom teeth);
  3. Diagnosis of AO based on the criteria of Blum (Blum 2002)
Read More
Exclusion Criteria
  1. Patients with chronic diseases and/or taking any medication, influencing hard and soft tissue healing;
  2. Pregnancy;
  3. History of hypersensitivity or allergy to HY;
  4. Inability to attend follow-up appointments; Intake of preoperative antibiotics.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Hyaluronic acidHyaluronic acid gelhyaluronic acid gel application
Hyaluronic acid+carrierHyaluronic acid gel + carrierhyaluronic acid gel application together with a carrier
Primary Outcome Measures
NameTimeMethod
Pain perception by the patient2 weeks

VAS- Visual analogue scale measured on a 10cm scale, where 0 represents no pain and 10 represents maximum pain

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Clinic of Dentistry, Medical University of Vienna

🇦🇹

Vienna, Austria

© Copyright 2025. All Rights Reserved by MedPath